Theradome announced that it has initiated one of the most comprehensive studies to date to evaluate its Theradome LH80 PRO Laser Helmet on men with thinning hair or who are showing signs of balding.
The double-blind, sham-controlled, randomized, multicenter study will test the Theradome Laser Helmet’s ability to promote hair growth in men aged 18–50 who have been diagnosed with androgenetic alopecia over the course of 26 weeks. Three medical centers in Georgia, Oregon, and Tennessee are currently recruiting male patients for the study.
The Theradome Laser Helmet is an over-the-counter (OTC) device that is presently cleared by the Food and Drug Administration (FDA) to promote hair growth in females with androgenetic alopecia. It utilizes low-level laser light therapy to stimulate weak hair follicles by providing them with targeted laser energy to improve cellular metabolism and protein synthesis required to grow and maintain hair. Typically, the Theradome Laser Helmet is worn twice a week for 20 minutes and many have reported positive results in as little as 18 weeks.
For more information visit Theradome.com.